Literature DB >> 6210645

Myoclonus and Huntington's chorea: description of a case.

P Previdi, R Borgonovi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6210645     DOI： 10.1007/bf02335850

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


× No keyword cloud information.
  6 in total

1.  Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy.

Authors:  A N Barr; W J Heinze; G D Dobben; G E Valvassori; O Sugar
Journal:  Neurology       Date:  1978-11       Impact factor: 9.910

2.  [Anatomoclinical study of a rigid and myoclonic form of Huntington's disease in children].

Authors:  R Fau; R Chateau; M Tommasi; R Groslambert; S Garrel; J Perret
Journal:  Rev Neurol (Paris)       Date:  1971-05       Impact factor: 2.607

3.  [Pharmacological analysis of a case of postanoxic intention and action myoclonus].

Authors:  F Lhermitte; M Peterfalvi; R Marteau; J Gazengel; M Serdaru
Journal:  Rev Neurol (Paris)       Date:  1971-01       Impact factor: 2.607

4.  Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.

Authors:  D Chadwick; M Hallett; R Harris; P Jenner; E H Reynolds; C D Marsden
Journal:  Brain       Date:  1977-09       Impact factor: 13.501

5.  Postanoxic action myoclonus (Lance-Adams syndrome) responding to valproate.

Authors:  R D Rollinson; B S Gilligan
Journal:  Arch Neurol       Date:  1979-01

6.  [Myoclonic type of Huntington's chorea (author's transl)].

Authors:  S Garrel; A Joannard; C Feuerstein; F Serre
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1978 Jan-Mar
  6 in total
  2 in total

1.  Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Authors:  Carsten Saft; Thorsten Lauter; Peter H Kraus; Horst Przuntek; Juergen E Andrich
Journal:  BMC Neurol       Date:  2006-02-28       Impact factor: 2.474

2.  International Guidelines for the Treatment of Huntington's Disease.

Authors:  Anne-Catherine Bachoud-Lévi; Joaquim Ferreira; Renaud Massart; Katia Youssov; Anne Rosser; Monica Busse; David Craufurd; Ralf Reilmann; Giuseppe De Michele; Daniela Rae; Ferdinando Squitieri; Klaus Seppi; Charles Perrine; Clarisse Scherer-Gagou; Olivier Audrey; Christophe Verny; Jean-Marc Burgunder
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.